Cargando…
Randomized double-blind placebo-controlled PK/PD study on the effects of a single intravenous dose of the anti-hepcidin Spiegelmer NOX-H94 on serum iron during experimental human endotoxemia
Autores principales: | Van Eijk, L, Swinkels, DW, John, A, Schwoebel, F, Fliegert, F, Summo, L, Vauleon, S, Laarakkers, JM, Riecke, K, Pickkers, P |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3642571/ http://dx.doi.org/10.1186/cc12290 |
Ejemplares similares
-
Safety, pharmacokinetics and pharmacodynamics of the anti‐hepcidin Spiegelmer lexaptepid pegol in healthy subjects
por: Boyce, M, et al.
Publicado: (2016) -
Tubular reabsorption and local production of urine hepcidin-25
por: Peters, Hilde PE, et al.
Publicado: (2013) -
Olaptesed pegol, an anti-CXCL12/SDF-1 Spiegelmer, alone and with bortezomib–dexamethasone in relapsed/refractory multiple myeloma: a Phase IIa Study
por: Ludwig, H, et al.
Publicado: (2017) -
Improved Mass Spectrometry Assay For Plasma Hepcidin: Detection and Characterization of a Novel Hepcidin Isoform
por: Laarakkers, Coby M. M., et al.
Publicado: (2013) -
Advances in Quantitative Hepcidin Measurements by Time-of-Flight Mass Spectrometry
por: Swinkels, Dorine W., et al.
Publicado: (2008)